BGOG-EN5 /ENGOT-EN5

Trial Description: 
A randomized, double-blind, phase 3 trial of maintenance with selixexor/placebo after combination chemotherapy for patients with advanced or recurrent endometrial cancer.
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Endometrial
Trial Status: 
Recruiting
Contact person: